FOSTER JONATHAN P. (Exec. Vice President and CFO) purchased 2377.1% of their position (293.33K shares) of MOLECULIN BIOTECH, INC. on the open market
Open‑market purchases signal personal conviction — classified as a major conviction buy.
P · 1 purchase
Filed: 8/5/2026ACC: 0001437749-26-025929
Officer· Exec. Vice President and CFO
Since Jul 2019
+1.17M
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
1.17M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+293.33K
Price / share
—
Trade value
—
% of position
2377.1%
8/3/2026
12.34K→305.67K
Total
Net shares
+293.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/3/2026 | P · Purchase | +293.33K | — | — | 2377.1% | 12.34K | 305.67K |
| Total | +293.33K | $0.00 | ||||||
Derivative Transactions1
Series I Warrants
Direct
Converts to
Common Stock
880K shares
Shares
+880K
Strike price
Held after
1.03M
Exercisable
—
8/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series I Warrants Direct | Common Stock880K shares | 8/3/2026 | P · Purchase | +880K | — | 1.03M |